2022 American Transplant Congress

TOPIC: Clinical Science » Heart » 63 - Heart and VADs: All Topics

Successful Outcome of Highly Sensitized Patients After Heart Transplantation Under RATG Regimen
G. Esmailian, T. Singer-Englar, J. Patel, M. Kittleson, S. Kim, N. Patel, D. Chang, E. Kransdorf, F. Esmailian, J. A. Kobashigawa
The Gut Microbiome in the Critical Care Setting Post-Heart Transplantation
M. Dela Cruz¹, H. Lin², E. Adler², M. Khalid², J. Boissiere², G. Kim¹, S. Pinney¹, E. Pamer², A. Nguyen¹
The New Heart Allocation Policy Has Increased Listing by Exception
J. R. Golbus¹, Y. Ahn², B. K. Nallamothu¹, M. N. Walsh³, D. Zaun², A. Israni², M. Colvin¹
The Post-operative Clinical Outcomes Of 59 Tanrp Cases In An International Cohort
J. Louca¹, N. Patel¹, S. Messer², J. Chindu², S. Large²
The Prevalence and Morbidity Associated with BK Virus in Heart Transplant Recipients
A. Nguyen¹, Z. Li², N. F. Rasheed², J. Cruz², M. Fei³, G. Kim¹, S. Pinney¹, N. Uriel⁴
The Role of Geography in Adult Heart Allocation Over the Last 5 Years
K. Bradbrook¹, R. Goff¹, R. Daly², S. Hall³
The Trajectory of Donor-Derived Cell-Free DNA (dd-cfDNA) Complements the Baseline Measurements in Heart Transplant Surveillance for Rejection
P. Shah¹, R. Cheng², H. Eisen³, B. D. Lowes⁴, L. Lourenco Jenkins⁵, Y. Fu⁵, K. Qu⁵, J. Teuteberg⁶, E. DePasquale⁷
The Use of Donor-Derived Cell-Free DNA in Female and Male Heart Transplant Recipients: A Sex-Specific Analysis of the Surveillance Heartcare Outcomes Registry
E. M. DeFilippis¹, Y. Fu², R. Burke², M. Deng³, M. Kamath⁴, L. Lourenco Jenkins², A. R. Vest⁵
Use of Pronase to Identify HLA Crossmatch Antibody Interference
N. Hendren¹, C. Lacelle¹, S. Carter¹, J. L. Grodin¹, E. Hardin², M. Farr³, S. Garg¹
Using Wearable Technology to Assess Activity in Children After Heart Transplant
J. B. Edelson¹, D. Gandla², S. M. Paridon¹, J. W. Rossano¹, M. J. O'Connor¹, M. Lane-Fall², B. Keating²